25I-NBOH
25I-NBOH (NBOH-2CI, Cimbi-27) je fenetilaminski halucinogen. On deluje kao potentan agonist 5HT2A receptora,[1][2] sa Ki od 0,061 nM na ljudskom 5HT2A receptoru, te je dvanaest puta potentniji od liganda 2C-I. In vitro testovi su pokazali da ovo jedinjenje deluje kao agonist, ali rezultati životinjskih studija nisu objavljeni. Dok su N-benzilni derivati 2C-I liganda znatno povećavali potentnost, N-benzil derivati 2,5-dimetoksi-4-jodoamfetamina su neaktivni.[3]
IUPAC ime | |
---|---|
2-((2-(4-jodo-2,5-dimetoksifenil)etilamino)metil)fenol | |
Identifikatori | |
CAS broj | 919797-20-9 |
ATC kod | none |
PubChem | CID 10001761 |
ChemSpider | 8177342 |
Hemijski podaci | |
Formula | C17H20INO3 |
Molarna masa | 413,249 g/mol |
| |
|
Reference
уреди- ^ Ettrup, A.; et al. (2010). „Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT2A agonist PET tracers”. European Journal of Nuclear Medicine and Molecular Imaging. 38 (4): 681—693. PMID 21174090. doi:10.1007/s00259-010-1686-8. ISBN 0-02-590101686-8.
- ^ Silva ME, Heim R, Strasser A, Elz S, Dove S (2011). „Theoretical studies on the interaction of partial agonists with the 5-HT(2A) receptor”. Journal of Computer-aided Molecular Design. 25 (1): 51—66. PMID 21088982. doi:10.1007/s10822-010-9400-2.
- ^ Braden, MR; Parrish, JC; Naylor, JC; Nichols, DE (2006). „Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists”. Molecular Pharmacology. 70 (6): 1956—64. PMID 17000863. doi:10.1124/mol.106.028720.
Vidi još
уреди- 2CBCB-NBOMe (NBOMe-TCB-2)
- 2CBFly-NBOMe (NBOMe-2CB-Fly)
- 25B-NBOMe (NBOMe-2CB)
- 2C-C-NBOMe (NBOMe-2CC)
- 25I-NBMD (NBMD-2CI)
- 25I-NBOMe (NBOMe-2CI)
- 2C-TFM-NBOMe (NBOMe-2C-TFM)
- 25I-NBF (NBF-2CI)